SS
EPIX

Steve Schonfeld’s ESSA Pharma EPIX Stock Holding History

Steve Schonfeld’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,343
Closed -$24.4K – 2302
2025
Q2 		$24.4K Sell
14,343
-8,500
-37% -$14.3K ﹤0.01% 1923
2025
Q1 		$36.1K Sell
22,843
-26,000
-53% -$44K ﹤0.01% 2081
2024
Q4 		$87.4K Sell
48,843
-229,157
-82% -$730K ﹤0.01% 1845
2024
Q3 		$1.68M Sell
278,000
-37,736
-12% -$207K 0.01% 958
2024
Q2 		$1.66M Sell
315,736
-52,764
-14% -$335K 0.01% 986
2024
Q1 		$3.13M Buy
+368,500
New +$3.22M 0.02% 818
2021
Q4 		– Sell
-10,600
Closed -$85K – 2244
2021
Q3 		$85K Sell
10,600
-76,456
-88% -$1.22M ﹤0.01% 1960
2021
Q2 		$2.49M Sell
87,056
-15,100
-15% -$439K 0.03% 651
2021
Q1 		$2.97M Buy
+102,156
New +$2.37M 0.04% 568

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Steve Schonfeld's EPIX Position: Q3 2025 in Review

Steve Schonfeld sold out of ESSA Pharma (EPIX) in Q3 2025, closing a stake of 14,343 shares — an estimated $24.4K sold.

Steve Schonfeld first reported a position in EPIX in Q1 2021 and held it in 9 quarters. The position peaked at $3.13M in Q1 2024. 32 funds tracked by Wall St. Rank hold EPIX as of Q3 2025.

  • Steve Schonfeld reported no remaining ESSA Pharma position as of Q3 2025 after selling out during the quarter.
  • Steve Schonfeld sold 14,343 ESSA Pharma shares in Q3 2025, an estimated $24.4K.
  • Steve Schonfeld first reported a position in ESSA Pharma in Q1 2021 and held it in 9 quarters.
  • Steve Schonfeld's ESSA Pharma position peaked at $3.13M in Q1 2024.
  • 32 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.